This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of anus and anal canal
C3_ANUS_ANALCANAL
anal neoplasm: A benign or malignant neoplasm that affects the anal canal or anal margin. Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
219 |
4. Check minimum number of eventsNone |
219 |
5. Include endpointsNone |
219 |
6. Filter based on genotype QC (FinnGen only) |
189 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of anus and anal canal
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of anus and anal canal, including Hilmo
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 189 | 118 | 71 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 66.95 | 64.27 | 71.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 196
- Matched controls
- 1960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C21.1
ICD-10 Finland
Malignant neoplasm: Anal canal
+∞
158.7
130
*
130
Kela drug reimbursment
Malignant tumour
+∞
127.4
108
*
A03FA01
ATC
metoclopramide; systemic, rectal
23.1
115.7
133
164
C21.0
ICD-10 Finland
Malignant neoplasm: Anus, unspecified
+∞
114.0
98
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
23.0
104.7
95
77
WF002
NOMESCO Finland
Radical radiotherapy
787.8
98.7
89
*
UJH02
NOMESCO Finland
Anoscopy
24.3
83.7
67
41
N02AA05
ATC
oxycodone; systemic
12.5
73.2
112
189
JN4BD
NOMESCO Finland
Extensive body CT
22.5
71.4
58
36
8070/3-C21.0
ICD-O-3
Squamous cell carcinoma, NOS, of anus, NOS
+∞
71.3
64
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
68.9
62
*
Z51.5
ICD-10 Finland
Palliative care
20.2
66.7
57
39
L01BC06
ATC
capecitabine; oral
+∞
66.5
60
*
8070/3-C21.1
ICD-O-3
Squamous cell carcinoma, NOS, of anal canal
+∞
63.0
57
*
A04AA01
ATC
ondansetron; systemic, rectal
22.0
57.6
46
27
JN4AD
NOMESCO Finland
Body CT examination
15.1
57.4
58
53
C21.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal
+∞
54.8
50
*
XX3DW
NOMESCO Finland
Time consuming IT work
15.6
51.8
50
42
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
50.2
46
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
+∞
47.9
44
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
298.4
47.2
46
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
46.8
43
*
A04AA02
ATC
granisetron; systemic, transdermal
525.4
44.0
42
*
H02AB02
ATC
dexamethasone; systemic
68.3
38.2
43
8
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
36.6
34
*
UJF32
NOMESCO Finland
Coloscopy
6.0
35.6
107
325
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
413.5
35.1
34
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
113.4
35.1
37
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
33.3
31
*
JG1BG
NOMESCO Finland
MRI of rectum
+∞
33.3
31
*
UJG02
NOMESCO Finland
Proctoscopy
43.8
32.0
39
11
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
31.1
29
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
30.0
28
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
32.1
29.8
39
15
JHA00
NOMESCO Finland
Anal or perianal incision
117.4
28.5
30
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.3
28.0
34
39
WZC00
NOMESCO Finland
Treatment plan or consultation
4.9
27.6
100
341
TPH07
NOMESCO Finland
Cathetrisation of artery
6.0
25.2
54
117
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
24.5
23
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
24.5
23
*
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
+∞
23.4
22
*
JHA10
NOMESCO Finland
Biopsy of anal canal
259.0
23.1
23
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
22.3
21
*
B01AB10
ATC
tinzaparin; parenteral
5.9
21.9
46
97
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
21.2
20
*
D75
ICPC
Malignant neoplasm colon/rectum
233.8
21.0
21
*
WX402
NOMESCO Finland
General anaesthesia
4.4
20.8
70
218
ZX090
NOMESCO Finland
Other technic of radiotherapy
117.0
20.0
21
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
18.4
19.5
30
19
WZC30
NOMESCO Finland
Teaching
4.8
19.3
53
140
ULA02
NOMESCO Finland
Kolposcopy
6.2
19.3
37
71
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
19.1
18
*
Z93.3
ICD-10 Finland
Colostomy status
+∞
19.1
18
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.3
18.9
44
101
ZX070
NOMESCO Finland
Intensity modified radiotherapy
209.2
18.9
19
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
18.0
17
*
WW500
NOMESCO Finland
Blood transfusion
16.1
17.4
28
20
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
16.9
16
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
30.7
16.9
22
8
ZZR00
NOMESCO Finland
Flap of skin
185.1
16.8
17
*
JFF23
NOMESCO Finland
Transversostomy
185.1
16.8
17
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
6.8
16.6
28
47
JHA20
NOMESCO Finland
Excision of lesion of anal canal or perianal tissue
23.5
16.4
23
11
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
19.3
16.1
24
14
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
15.8
15
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
15.8
15
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
15.8
15
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
14.1
15.4
26
21
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
14.8
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.8
14
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
14.8
14
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
14.8
14
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
161.5
14.7
15
*
L03AA13
ATC
pegfilgrastim; parenteral
80.9
13.8
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
13.7
13
*
TJF80
NOMESCO Finland
Ostomy education
+∞
13.7
13
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
13.7
13
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
13.7
69
274
R4110
NOMESCO Finland
Physiotherapy
3.2
13.3
75
318
WX600
NOMESCO Finland
Single shot through catheter
74.8
12.8
14
*
JG1DG
NOMESCO Finland
Very extensive MRI of rectum
+∞
12.6
12
*
JGB36
NOMESCO Finland
Wide excision of rectum
+∞
12.6
12
*
115
Kela drug reimbursment
Breast cancer
+∞
12.6
12
*
R50.9
ICD-10 Finland
Fever, unspecified
3.8
12.5
46
148
P01AB01
ATC
metronidazole; oral, rectal
2.9
12.3
110
596
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.2
12.2
22
39
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.4
12.1
34
90
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.8
11.9
23
44
K62.9
ICD-10 Finland
Disease of anus and rectum, unspecified
69.2
11.7
13
*
B01AB05
ATC
enoxaparin; parenteral
2.9
11.6
87
426
JGB37
NOMESCO Finland
Laparoscopic wide excision of rectum
+∞
11.6
11
*
A79
ICPC
Malignancy NOS
+∞
11.6
11
*
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
127.2
11.6
12
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.5
11.4
14
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
11.4
39
119
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
11.0
62
259
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
10.5
10
*
C21.2
ICD-10 Finland
Malignant neoplasm: Cloacogenic zone
+∞
10.5
10
*
SPAT1125
SPAT
Stoma care and guidance
20.1
10.4
15
8
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
10.9
10.3
19
19
JN4CD
NOMESCO Finland
Very extensive body CT
17.9
10.0
15
9
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
104.9
9.5
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
+∞
9.4
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
9.4
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.4
9
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.6
9.3
34
108
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
9.1
48
191
K60.2
ICD-10 Finland
Anal fissure, unspecified
19.8
9.1
13
7
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.4
8.8
23
57
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
93.9
8.5
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.5
8.5
15
14
N02AX02
ATC
tramadol; systemic, rectal
2.4
8.4
105
634
8140/3-C21.1
ICD-O-3
Adenocarcinoma, NOS, of anal canal
+∞
8.4
8
*
8140/3-C21.0
ICD-O-3
Adenocarcinoma, NOS, of anus, NOS
+∞
8.4
8
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.4
8
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.4
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.4
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
+∞
8.4
8
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
10.7
8.2
15
15
K61.0
ICD-10 Finland
Anal abscess
23.2
8.1
11
5
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.2
7.9
22
57
K60.3
ICD-10 Finland
Anal fistula
15.9
7.8
12
8
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
7.7
30
99
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.1
7.6
22
59
ZXE00
NOMESCO Finland
One hour or less
2.3
7.4
86
496
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
+∞
7.3
7
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.3
7
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
+∞
7.3
7
*
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
+∞
7.3
7
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
7.3
7
*
C211, 8085, 3
ICD-O-3
+∞
7.3
7
*
C80.91
ICD-10 Finland
Malignant tumor without specified localization epidermoid carcinoma
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
LEB00
NOMESCO Finland
Biopsy of vagina
16.5
7.3
11
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
7.3
46
200
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.1
7.3
17
26
L02BG04
ATC
letrozole; oral
31.3
7.2
9
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
21.0
7.2
10
5
Z2221
NOMESCO Finland
Medical doctor
2.4
7.1
63
322
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
6.3
7.1
18
31
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
7.1
87
512
ZXD05
NOMESCO Finland
Urgent procedure
2.4
7.0
67
354
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
6.9
36
141
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
6.9
80
458
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
6.9
37
148
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
41.5
6.8
8
*
ZX120
NOMESCO Finland
Intravenous
3.9
6.8
21
59
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.3
6.8
17
29
A28
ICPC
Limited function/disability NOS
2.4
6.7
56
278
S97
ICPC
Chronic ulcer skin
3.5
6.5
24
76
D17
ICPC
Incontinence of bowel
15.0
6.5
10
7
L02BA01
ATC
tamoxifen; oral
72.1
6.5
7
*
Z43.3
ICD-10 Finland
Attention to colostomy
72.1
6.5
7
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
72.1
6.5
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
72.1
6.5
7
*
L03AA02
ATC
filgrastim; parenteral
72.1
6.5
7
*
JHW96
NOMESCO Finland
Other operation on anus or perianal tissue
72.1
6.5
7
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.6
6.4
13
16
TQW99
NOMESCO Finland
Other minor procedure on skin
5.4
6.4
18
36
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.7
6.3
15
24
A02BC02
ATC
pantoprazole; systemic
2.3
6.3
146
1090
ZZR30
NOMESCO Finland
Flap of muscle
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
JG1CM
NOMESCO Finland
Extensive MRI of rectum (more than 1.5 T)
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
JFF27
NOMESCO Finland
Laparoscopic sigmoidostomy
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
Z3231
NOMESCO Finland
Registered nurse
2.3
6.3
61
323
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
8.1
6.2
13
17
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
9.0
6.1
12
14
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
6.1
53
267
R4190
NOMESCO Finland
Nutritional therapy
7.6
6.0
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
132
87
44.40
167.83
4.4
1.4
5.02
2.69
ug/l
3.11
106
67
153
719
6.14
28.28
9.5
3.8
33.37
35.71
g/l
4.54
148
673
167
846
7.58
28.24
12.5
3.6
8.94
11.68
umol/l
7.69
162
791
161
852
5.98
24.01
16.7
6.1
3.87
4.19
e9/l
0.92
139
737
119
556
3.90
19.57
7.5
2.1
2.38
2.35
mmol/l
0.89
113
496
58
179
4.18
17.14
2.4
2.0
14.33
7.54
umol/l
0.68
49
155
135
726
3.76
17.10
5.1
2.3
—
—
estimate
—
0
0
88
375
3.44
15.92
4.9
1.9
—
—
—
0
0
60
223
3.44
13.17
13.6
6.1
104.90
104.17
mmol/l
0.60
60
223
38
108
4.12
12.30
2.0
1.4
—
—
—
0
0
46
154
3.60
11.76
2.7
1.9
30.39
36.05
u/l
0.42
38
126
76
348
2.93
11.48
5.4
2.0
2.50
2.43
mmol/l
6.92
71
309
126
754
2.88
11.39
11.2
5.6
1.20
1.21
mmol/l
1.34
118
683
135
859
2.84
10.48
12.2
6.1
1.20
1.21
mmol/l
1.03
124
746
61
262
2.93
10.20
3.8
3.2
1.05
3.03
e6/l
1.61
31
120
25
61
4.55
9.77
1.9
1.7
7.53
2.75
ug/l
0.66
25
53
50
205
2.93
8.99
12.0
7.0
5.06
5.11
kpa
0.17
50
197
50
205
2.93
8.99
11.9
7.0
13.10
10.74
kpa
3.06
50
198
82
435
2.52
8.85
2.6
2.2
3.23
2.89
mg/l
0.38
70
369
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
45
4.84
8.58
2.3
2.0
0.31
0.49
iu/ml
—
5
24
62
291
2.65
8.58
3.7
2.8
0.56
1.38
e6/l
1.43
32
149
84
457
2.47
8.52
5.1
2.9
0.33
0.38
e6/l
0.09
57
323
100
593
2.40
8.32
5.9
3.1
—
—
—
0
0
7
0
+∞
7.33
1.3
0.0
—
—
—
0
0
57
283
2.43
6.84
2.5
1.7
—
—
—
0
0
18
35
5.55
6.51
2.5
2.8
4.95
4.16
g/l
0.81
18
35
44
208
2.44
5.80
2.2
1.7
—
—
—
0
0
53
273
2.29
5.76
2.4
1.8
29.65
29.25
s
0.18
53
261
27
101
2.94
5.61
2.3
1.5
—
—
—
0
0
8
5
16.58
5.45
2.9
1.0
14.57
15.80
u/ml
—
8
5
109
758
1.99
5.24
3.6
3.0
191.85
123.89
ug/l
1.09
102
702
15
40
3.98
5.20
1.7
1.5
—
—
—
0
0
15
41
3.88
5.03
1.3
1.2
—
—
—
0
0
44
223
2.25
4.91
2.3
1.7
—
—
—
0
0
36
170
2.37
4.72
4.2
1.8
223.47
236.51
u/l
0.20
36
156
11
20
5.76
4.35
2.8
1.3
—
289.40
—
0
5
6
5
12.32
3.78
1.2
1.2
—
—
—
0
0
12
30
4.19
3.66
1.1
1.3
—
—
—
0
0
12
30
4.19
3.66
1.1
1.3
—
—
—
0
0
111
845
1.72
3.43
2.3
2.2
87.49
97.87
pmol/l
1.73
64
418
36
196
2.02
3.31
6.1
3.3
1.62
2.01
mmol/l
0.26
30
171
41
239
1.90
3.10
1.8
1.5
—
—
—
0
0
79
565
1.67
2.96
1.9
1.8
18.88
20.00
nmol/l
0.23
67
473
15
58
2.72
2.95
2.4
3.5
—
—
—
0
0
35
197
1.95
2.93
6.3
3.3
5.52
5.83
kpa
1.33
35
191
13
47
2.89
2.88
1.9
1.6
—
—
—
0
0
13
48
2.83
2.78
1.1
1.2
—
—
—
0
0
58
388
1.70
2.77
1.9
1.7
1.13
1.12
mg/l
0.01
46
305
13
49
2.77
2.68
1.3
1.4
—
—
—
0
0
149
1274
1.71
2.61
5.4
4.7
24.93
12.32
mm/h
7.98
138
1175
6
11
5.59
2.56
2.2
1.4
58.83
36.33
u/l
—
6
6
178
1610
2.15
2.54
37.9
14.2
32.03
23.12
mg/l
3.72
170
1302
11
38
3.00
2.46
1.5
1.2
—
—
—
0
0
11
40
2.85
2.31
2.7
1.5
—
—
—
0
0
28
162
1.85
2.16
6.6
3.0
—
—
—
0
0
98
783
1.50
2.10
2.8
2.5
70.74
78.99
nmol/l
2.73
87
695
5
10
5.10
2.08
1.2
1.1
—
—
—
0
0
54
381
1.58
2.04
3.1
4.0
65.64
295.57
ng/l
1.26
47
315
59
779
0.65
1.98
1.9
1.9
1.43
1.30
mmol/l
0.72
54
661
7
21
3.42
1.98
2.3
1.7
—
—
—
0
0
17
87
2.04
1.86
1.3
1.4
—
—
—
0
0
5
12
4.24
1.83
2.8
1.2
—
—
—
0
0
148
1307
1.54
1.83
48.2
17.3
14.56
13.63
%
9.44
148
1291
26
157
1.76
1.76
2.5
3.5
152.30
209.85
ng/l
0.57
20
141
19
104
1.92
1.74
5.7
2.5
0.60
0.63
%
0.18
19
104
10
41
2.51
1.67
1.6
1.6
—
—
—
0
0
8
32
2.56
1.61
1.3
1.1
—
—
—
0
0
19
107
1.86
1.61
5.7
2.4
0.92
1.21
%
1.36
19
107
26
163
1.69
1.56
5.0
2.7
3.50
4.44
kpa
4.16
26
156
108
914
1.40
1.54
6.2
4.1
0.00
0.02
estimate
0.68
21
162
23
141
1.72
1.50
6.7
2.3
61.78
62.94
ml/min/173m2
—
9
52
152
1643
0.67
1.49
4.9
5.6
1.47
1.51
mmol/l
0.52
140
1511
5
16
3.18
1.44
2.2
1.5
2.96
2.67
u/ml
—
5
16
5
16
3.18
1.44
1.0
1.2
—
—
—
0
0
5
16
3.18
1.44
1.6
1.1
—
—
—
0
0
105
892
1.38
1.43
6.0
4.1
0.00
0.00
estimate
-0.00
18
170
24
151
1.67
1.43
3.5
2.4
0.22
0.32
e6/l
0.39
24
139
154
1653
0.68
1.33
5.8
5.6
6.00
6.02
mmol/l
0.06
140
1510
44
326
1.45
1.30
1.7
1.7
1041.09
1189.74
nmol/l
0.63
34
247
5
18
2.82
1.29
1.2
1.1
—
173.49
—
0
7
122
1075
1.36
1.25
3.8
3.1
82.45
46.19
u/l
0.88
117
1007
146
1574
0.72
1.18
4.2
4.7
1.35
1.25
mmol/l
1.10
133
1434
104
902
1.33
1.15
6.2
4.1
0.00
0.00
estimate
-0.00
21
175
159
1684
0.70
1.06
5.7
6.6
2.71
2.66
mmol/l
0.27
146
1554
10
53
1.93
1.03
1.1
1.2
—
—
—
0
0
10
53
1.93
1.03
1.1
1.2
—
—
—
0
0
16
246
0.62
1.03
1.3
1.5
—
—
—
0
0
156
1653
0.72
0.98
4.9
5.7
4.67
4.60
mmol/l
0.31
144
1527
11
62
1.82
0.96
2.6
1.6
—
—
—
0
0
74
629
1.28
0.90
2.8
3.2
1418.46
1417.07
ng/l
0.00
67
535
153
1621
0.74
0.90
6.7
7.2
39.70
39.80
mmol/mol
0.05
141
1511
6
32
1.90
0.82
1.3
1.6
—
—
—
0
0
10
58
1.76
0.81
2.6
1.5
—
—
—
0
0
167
1590
1.34
0.72
38.0
13.3
78.52
75.83
ml/min/173m2
0.97
161
1476
5
27
1.87
0.69
1.0
1.1
—
—
—
0
0
64
730
0.82
0.63
5.1
3.9
67.62
151.23
ng/l
0.43
51
530
96
873
1.20
0.58
3.0
2.7
—
—
—
0
0
6
36
1.69
0.57
1.5
1.6
—
—
—
0
0
11
158
0.68
0.55
1.3
1.4
—
—
—
0
0
6
40
1.52
0.52
1.0
1.7
0.88
0.82
nmol/l
—
6
31
6
40
1.52
0.52
3.5
1.2
—
—
—
0
0
32
385
0.80
0.52
3.0
3.9
16.82
23.74
%
2.74
14
177
57
499
1.20
0.51
6.7
4.0
0.00
0.00
estimate
-0.00
19
156
179
1742
1.32
0.45
47.1
19.0
79.07
78.39
umol/l
0.08
179
1714
10
70
1.45
0.42
1.1
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
27
314
0.84
0.33
1.3
1.3
3.51
12.31
u/ml
—
9
109
7
52
1.36
0.31
4.7
5.0
22.76
25.32
mmol/l
—
7
45
7
54
1.31
0.30
1.6
1.2
—
—
—
0
0
10
76
1.33
0.28
1.6
1.4
—
—
—
0
0
20
234
0.84
0.26
11.5
7.2
—
—
—
0
0
31
347
0.87
0.24
1.5
1.3
23.38
32.23
iu/ml
—
8
108
44
401
1.13
0.24
1.6
1.8
389.34
448.33
pmol/l
0.85
38
332
11
88
1.26
0.23
1.9
1.5
—
—
—
0
0
53
491
1.11
0.22
3.4
4.3
1.48
1.96
ug/l
0.72
45
438
49
453
1.11
0.21
3.1
2.4
343.00
348.75
umol/l
0.13
43
390
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
71.01
—
0
14
8
72
1.12
0.16
1.3
2.4
38.75
42.20
u/l
—
8
64
40
375
1.08
0.13
1.2
1.3
0.44
1.57
u/ml
—
9
106
66
688
0.94
0.13
6.9
3.9
0.00
0.03
estimate
0.80
15
131
67
698
0.94
0.13
4.2
4.1
11.91
7.51
mg/mmol
0.47
45
425
10
85
1.19
0.12
1.0
1.0
—
—
—
0
0
26
280
0.92
0.11
1.8
2.8
0.46
0.77
ug/l
2.59
14
184
22
237
0.92
0.09
6.0
5.5
33.56
32.36
%
0.16
16
143
6
57
1.05
0.08
1.3
1.1
—
—
—
0
0
134
1324
1.04
0.06
4.8
4.3
15.07
14.91
pmol/l
0.30
124
1206
48
469
1.03
0.03
6.1
3.5
0.00
0.00
estimate
-0.00
17
141
156
1562
0.99
0.00
5.9
5.5
2.02
1.96
mu/l
0.22
147
1421
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
12.00
—
0
7
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
3.1
—
13.46
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1627.67
—
0
6
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
9.38
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
11
110
1.00
-0.00
7.5
3.6
4.76
5.13
kpa
1.22
11
104
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
11.20
—
0
6
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
73.00
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
64.50
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ANUS_ANALCANAL – Malignant neoplasm of anus and anal canal
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).